| Hepatitis E virus: advances and challenges I Nimgaonkar, Q Ding, RE Schwartz, A Ploss Nature Reviews Gastroenterology & Hepatology 15 (2), 96-110, 2018 | 290 | 2018 |
| Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2 Y Liu, G Hu, Y Wang, W Ren, X Zhao, F Ji, Y Zhu, F Feng, M Gong, X Ju, ... Proceedings of the National Academy of Sciences 118 (12), e2025373118, 2021 | 229 | 2021 |
| A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry Y Zhu, F Feng, G Hu, Y Wang, Y Yu, Y Zhu, W Xu, X Cai, Z Sun, W Han, ... Nature communications 12 (1), 961, 2021 | 219 | 2021 |
| Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles Q Ding, B Heller, JMV Capuccino, B Song, I Nimgaonkar, G Hrebikova, ... Proceedings of the National Academy of Sciences 114 (5), 1147-1152, 2017 | 217 | 2017 |
| Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species R Wang, Q Zhang, J Ge, W Ren, R Zhang, J Lan, B Ju, B Su, F Yu, P Chen, ... Immunity 54 (7), 1611-1621. e5, 2021 | 205 | 2021 |
| Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity Q Ding, X Cao, J Lu, B Huang, YJ Liu, N Kato, HB Shu, J Zhong Journal of hepatology 59 (1), 52-58, 2013 | 195 | 2013 |
| Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease Q Ding, JM Gaska, F Douam, L Wei, D Kim, M Balev, B Heller, A Ploss Proceedings of the National Academy of Sciences 115 (27), E6310-E6318, 2018 | 176 | 2018 |
| In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs L Sun, P Li, X Ju, J Rao, W Huang, L Ren, S Zhang, T Xiong, K Xu, X Zhou, ... Cell 184 (7), 1865-1883. e20, 2021 | 157 | 2021 |
| Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry J Ge, R Wang, B Ju, Q Zhang, J Sun, P Chen, S Zhang, Y Tian, S Shan, ... Nature communications 12 (1), 250, 2021 | 120 | 2021 |
| A novel cell culture system modeling the SARS-CoV-2 life cycle X Ju, Y Zhu, Y Wang, J Li, J Zhang, M Gong, W Ren, S Li, J Zhong, ... PLoS pathogens 17 (3), e1009439, 2021 | 115 | 2021 |
| MDA5 plays a critical role in interferon response during hepatitis C virus infection X Cao, Q Ding, J Lu, W Tao, B Huang, Y Zhao, J Niu, YJ Liu, J Zhong Journal of hepatology 62 (4), 771-778, 2015 | 110 | 2015 |
| The impact of hepatitis C virus entry on viral tropism Q Ding, M Von Schaewen, A Ploss Cell host & microbe 16 (5), 562-568, 2014 | 91 | 2014 |
| SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production L Luo, Z Li, T Zhao, X Ju, P Ma, B Jin, Y Zhou, S He, J Huang, X Xu, Y Zou, ... Science bulletin 66 (12), 1194-1204, 2021 | 90 | 2021 |
| A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles W Tao, C Xu, Q Ding, R Li, Y Xiang, J Chung, J Zhong Virology 395 (1), 67-76, 2009 | 66 | 2009 |
| Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2 S Zhang, W Huang, L Ren, X Ju, M Gong, J Rao, L Sun, P Li, Q Ding, ... Cell Research 32 (1), 9-23, 2022 | 56 | 2022 |
| Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption W Ren, J Lan, X Ju, M Gong, Q Long, Z Zhu, Y Yu, J Wu, J Zhong, ... PLoS Pathogens 17 (11), e1010053, 2021 | 52 | 2021 |
| Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathway Y Liang, X Cao, Q Ding, Y Zhao, Z He, J Zhong PLoS pathogens 14 (5), e1007075, 2018 | 52 | 2018 |
| Hepatitis C virus NS 3/4 A protease blocks IL28 production Q Ding, B Huang, J Lu, YJ Liu, J Zhong European journal of immunology 42 (9), 2374-2382, 2012 | 41 | 2012 |
| Genetic dissection of the host tropism of human-tropic pathogens F Douam, JM Gaska, BY Winer, Q Ding, M Von Schaewen, A Ploss Annual review of genetics 49, 21-45, 2015 | 40 | 2015 |
| An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants X Chi, X Zhang, S Pan, Y Yu, Y Shi, T Lin, H Duan, X Liu, W Chen, X Yang, ... Signal transduction and targeted therapy 7 (1), 44, 2022 | 37 | 2022 |
